Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats

References

• Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355–369.10.1016/S1474-4422(09)70025-0
   PubMed Web of Science ®Google Scholar
• Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182–187.10.1016/S1474-4422(07)70031-5
   PubMed Web of Science ®Google Scholar
• Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:169–171.
   Web of Science ®Google Scholar
• Kato H, Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol. 1999;19:93–108.10.1023/A:1006920725663
   PubMed Web of Science ®Google Scholar
• Ritz MF, Curina Y, Mendelowitschb A, et al. Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats. Brain Res. 2008;1239:226–234.10.1016/j.brainres.2008.08.073
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Black SE, Hakim AM. Heart and stroke foundation of ontario centre of excellence in stroke recovery. toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123–2136.10.1161/01.STR.0000025518.34157.51
   PubMed Web of Science ®Google Scholar
• Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRX. 2004;1:36–45.10.1602/neurorx.1.1.36
   PubMedGoogle Scholar
• Hoffman GE, Merchenthaler I, Zup SL. Neuroprotection by Ovarian Hormones in animal models of neurological disease. Endocrine. 2006;29:217–232.10.1385/ENDO:29:2
   PubMed Web of Science ®Google Scholar
• Menzie J, Prentice H, Wu JY. Neuroprotective mechenisms of taurine against ishemic stroke. Brain Sci. 2013;3:877–907.10.3390/brainsci3020877
   PubMedGoogle Scholar
• Sun M, Xu C. Neuroprotective mechanism of taurine due to upregulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia cellular and molecular neurobiology. Cell Mol Neurobiol. 2008;28:593–611.10.1007/s10571-007-9183-8
   PubMed Web of Science ®Google Scholar
• Schuller-Levis GB, Park E. Taurine and its chloramine: modulators of immunity. Neurochem Res. 2004;29:117–126.10.1023/B:NERE.0000010440.37629.17
   PubMed Web of Science ®Google Scholar
• Cui L, Zhang X, Yang R, et al. Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. Pharmacol Biochem Behav. 2010;96:469–475.10.1016/j.pbb.2010.07.007
   PubMed Web of Science ®Google Scholar
• Jin G, Arai K, Murata Y, et al. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke. 2008;39:2538–2543.10.1161/STROKEAHA.108.514927
   PubMed Web of Science ®Google Scholar
• Nito C, Kamada H, Endo H, et al. Role of the p38 mitogenactivated protein kinase/cytosolic phospholipase A2 signaling pathway in bloodbrain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 2008;28:1686–1696.10.1038/jcbfm.2008.60
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.10.1161/01.STR.20.1.84
   PubMed Web of Science ®Google Scholar
• Yang C, Zhang X, Fan H, et al. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res. 2009;1282:133–141.10.1016/j.brainres.2009.05.009
   PubMed Web of Science ®Google Scholar
• Zhang JW, Gottschall PE. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods. 1997;76:15–20.10.1016/S0165-0270(97)00065-4
   PubMed Web of Science ®Google Scholar
• Tatlisumak T, Carano RA, Takano K, et al. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke. 1998;29:850–857.10.1161/01.STR.29.4.850
   PubMed Web of Science ®Google Scholar
• Cui L, Zhang X, Yang R, et al. Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats. Neurol Res. 2011;33:319–324.10.1179/016164110X12759951866876
   PubMed Web of Science ®Google Scholar
• Wang GH, Jiang ZL, Fan XJ, et al. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors. Neuropharmacology. 2007;52:1199–1209.10.1016/j.neuropharm.2006.10.022
   PubMed Web of Science ®Google Scholar
• Gabryel B, Chalimoniuk M, Stolecka A, et al. Activation of cPLA2 and sPLA2 in astrocytes exposed to simulated ischemia in vitro. Cell Biol Int. 2007;31:958–965.10.1016/j.cellbi.2007.03.005
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009;7:97.10.1186/1479-5876-7-97
   PubMed Web of Science ®Google Scholar
• Pan C, Giraldo GS, Prentice H, et al. Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress. J Biomed Sci. 2010;17 (Suppl 1):S17.10.1186/1423-0127-17-S1-S17
   PubMed Web of Science ®Google Scholar
• Schuller-Levis GB, Park E. Taurine and its chloramine: modulators of immunity. Neurochem Res. 2004;29:117–126.10.1023/B:NERE.0000010440.37629.17
   PubMed Web of Science ®Google Scholar
• Sun HL, Li L, Shang L, et al. Cardioprotective effects and underlying mechanisms of oxymatrine against Ischemic myocardial injuries of rats. Phytother Res. 2008;22:985–989.
   PubMed Web of Science ®Google Scholar